The finding that SNO‐gephyrin is downregulated by exercise to alleviate anxiety not only provides a potential target for the prevention and intervention of anxiety, but also provides clues for the development of more effective exercise prescriptions for the treatment of anxiety and mood disorders. The gene discussed is GPHN; the disease is mood disorder.